Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-22-017398

Chief Business Development Off sold 2,670 shares at $12.01 ($32,067)

  • Chief Business Development Off acquired 82,372 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BENZENO SHARON Chief Business Development Off 2022-03-04 Grant or award +82,372 105,266 D: show line 1 in the form
BENZENO SHARON Chief Business Development Off 2022-03-07 Sale −2,670 $12.01 $32,067 102,596 D: show line 2 in the form
Open-market sales · 2,670 sh · avg $12.01 · $32,067

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
BENZENO SHARON Chief Business Development Off 2022-03-04 Grant or award · Stock Option (Right to Buy) +205,931 205,931 D: show line 3 in the form
Loading xslF345X03/doc4.xml…